Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. COVID-19 patients with severe disease were significantly less likely to require mechanical ...
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced encouraging initial data from an ongoing Phase 1/2/3 clinical trial of the Regeneron antibody cocktail, casirivimab and imdevimab, in ...
Among hospitalized COVID-19 patients, the use of high-flow oxygen through a nasal cannula reduced the need for invasive mechanical ventilation and sped up recovery compared to conventional oxygen ...
Please provide your email address to receive an email when new articles are posted on . Higher dose vs. low dose corticosteroids raises the risk for mortality by 60% in this patient population. Those ...
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced encouraging initial data from an ongoing Phase 1/2/3 clinical trial of the Regeneron antibody cocktail, casirivimab and imdevimab, in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results